loading page

Durability of mitral isthmus ablation with and without ethanol infusion in the vein of Marshall
  • +1
  • Masayuki Ishimura,
  • Masashi Yamamoto,
  • Toshiharu Himi,
  • Yoshio Kobayashi
Masayuki Ishimura
Kimitsu Chuo Byoin

Corresponding Author:marnet0826@me.com

Author Profile
Masashi Yamamoto
Kimitsu Chuo Hospital
Author Profile
Toshiharu Himi
Kimitsu Chuo Hospital
Author Profile
Yoshio Kobayashi
Chiba University Graduate School of Medicine School of Medicine
Author Profile

Abstract

Background: It is established that ethanol infusion in the vein of Marshall (EIVOM) effectively creates a linear ablation lesion in the mitral isthmus (MI). However, data on the long-term success rates of MI ablation remains limited. Methods and Results: Our cohort consisted of 560 patients with non-paroxysmal atrial fibrillation (AF) who underwent an initial MI ablation. Ablations were performed by only radiofrequency (RF) in 384 patients (RF group) or by RF and EIVOM in 176 patients (EIVOM/RF group). Ethanol of 5 mL was used to perform EIVOM in advance of RF. Following EIVOM, RF pulses were delivered to the lateral MI line. Bidirectional MI block was fully achieved in 353 (first 318, re-do 35) patients of the RF group and 171 (first 128, re-do 43) patients of the EIVOM/RF group (p = 0.09 in the first, 0.10 in the re-do ablation cases). In cases with complete MI line block, recurrent AF or atrial tachycardia (AT) was observed in 130 (37%) patients of the RF group and in 64 (37%) patients of the EIVOM/RF group (log-rank p = 0.12 in the first, 0.30 in the re-do ablation cases). Of the total 194 patients, 112 with drug refractory AF or AT proceeded to the subsequent ablation process. Reconnection of MI block line was observed in 39 (49%) patients in the RF group and 25 (58%) patients in the EIVOM/RF group (p = 0.32). Conclusion: EIVOM effectively ensures MI line block; however, the reconnection rate was similar between the two groups.
18 Mar 2021Submitted to Journal of Cardiovascular Electrophysiology
18 Mar 2021Submission Checks Completed
18 Mar 2021Assigned to Editor
19 Mar 2021Reviewer(s) Assigned
08 Apr 2021Review(s) Completed, Editorial Evaluation Pending
11 Apr 2021Editorial Decision: Revise Minor
08 May 20211st Revision Received
12 May 2021Submission Checks Completed
12 May 2021Assigned to Editor
12 May 2021Reviewer(s) Assigned
15 May 2021Review(s) Completed, Editorial Evaluation Pending
17 May 2021Editorial Decision: Accept
Aug 2021Published in Journal of Cardiovascular Electrophysiology volume 32 issue 8 on pages 2116-2126. 10.1111/jce.15107